Literature DB >> 12019399

Morbidity and mortality of gastrectomy for cancer in Department of Veterans Affairs Medical Centers.

Erik M Grossmann1, Walter E Longo, Katherine S Virgo, Frank E Johnson, Charles A Oprian, William Henderson, Jennifer Daley, Shukri F Khuri.   

Abstract

BACKGROUND: The purpose of this study was to define risk factors that predict 30-day morbidity and mortality after gastrectomy for cancer in Veterans Affairs (VA) Medical Centers.
METHODS: The VA National Surgical Quality Improvement Program prospectively collected data on 708 patients undergoing gastrectomy for cancer in 123 participating VA medical centers from 1991 to 1998. Independent variables included 68 preoperative patient characteristics and 12 intraoperative variables; the dependent variables were 21 defined adverse outcomes and death. Predictive models for 30-day morbidity and mortality were constructed by using stepwise logistic regression analysis.
RESULTS: The 30-day morbidity rate was 33.3% (236 of 708). The overall 30-day mortality rate was 7.6% (54 of 708). Significant positive predictors of morbidity (P <.05) included current pneumonia, American Society of Anesthesiologists class IV (threat to life), partially dependent functional status, dyspnea on minimal exertion, preoperative transfusion, extended operative time, and increasing age. Significant positive predictors of mortality (P <.05) included do not resuscitate status, prior stroke, intraoperative transfusion, preoperative weight loss, preoperative transfusion, and elevated preoperative alkaline phosphatase level.
CONCLUSIONS: Risk factors predicting morbidity and mortality rates at VA hospitals after gastrectomy for gastric cancer are reported by using a prospectively collected, multi-institutional database. Assigning relative weights to factors associated with adverse outcomes may help improve patient care.

Entities:  

Mesh:

Year:  2002        PMID: 12019399     DOI: 10.1067/msy.2002.123806

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  19 in total

1.  Risk factors related to operative morbidity in patients undergoing gastrectomy for gastric cancer.

Authors:  A Gil-Rendo; J L Hernández-Lizoain; F Martínez-Regueira; A Sierra Martínez; F Rotellar Sastre; M Cervera Delgado; V Valentí Azcarate; C Pastor Idoate; J Alvarez-Cienfuegos
Journal:  Clin Transl Oncol       Date:  2006-05       Impact factor: 3.405

2.  Risk factors for operative morbidity and mortality in gastric cancer patients undergoing total gastrectomy.

Authors:  Dao-Jun Gong; Chao-Feng Miao; Qi Bao; Ming Jiang; Li-Fang Zhang; Xiao-Tao Tong; Li Chen
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

3.  Underutilization of Treatment for Regional Gastric Cancer Among the Elderly in the USA.

Authors:  Natalie Liu; Daniela Molena; Miloslawa Stem; Amanda L Blackford; David B Sewell; Anne O Lidor
Journal:  J Gastrointest Surg       Date:  2018-02-05       Impact factor: 3.452

4.  A preoperative nomogram to predict the risk of perioperative mortality following gastric resections for malignancy.

Authors:  Mashaal Dhir; Lynette M Smith; Fred Ullrich; Premila D Leiphrakpam; Quan P Ly; Aaron R Sasson; Chandrakanth Are
Journal:  J Gastrointest Surg       Date:  2012-09-05       Impact factor: 3.452

5.  Comprehensive geriatric assessment in patients with gastric and gastroesophageal adenocarcinoma undergoing gastrectomy.

Authors:  Deep Pujara; Paul Mansfield; Jaffer Ajani; Mariela Blum; Elena Elimova; Yi-Ju Chiang; Prajnan Das; Brian Badgwell
Journal:  J Surg Oncol       Date:  2015-10-19       Impact factor: 3.454

6.  Adjuvant Therapy Completion Rates in Patients with Gastric Cancer Undergoing Perioperative Chemotherapy Versus a Surgery-First Approach.

Authors:  Eva Fuentes; Rima Ahmad; Theodore S Hong; Jeffrey W Clark; Eunice L Kwak; David W Rattner; John T Mullen
Journal:  J Gastrointest Surg       Date:  2015-09-22       Impact factor: 3.452

7.  Determinants of long-term survival after major surgery and the adverse effect of postoperative complications.

Authors:  Shukri F Khuri; William G Henderson; Ralph G DePalma; Cecilia Mosca; Nancy A Healey; Dharam J Kumbhani
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

Review 8.  Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectives.

Authors:  Alberto Biondi; Maria C Lirosi; Domenico D'Ugo; Valeria Fico; Riccardo Ricci; Francesco Santullo; Antonia Rizzuto; Ferdinando Cm Cananzi; Roberto Persiani
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

9.  Feasibility of Total Gastrectomy with D2 Lymphadenectomy for Gastric Cancer and Predictive Factors for Its Short- and Long-Term Outcomes.

Authors:  Fan-Feng Chen; Dong-Dong Huang; Jin-Xiao Lu; Chong-Jun Zhou; Cheng-Le Zhuang; Su-Lin Wang; Xian Shen; Zhen Yu; Xiao-Lei Chen
Journal:  J Gastrointest Surg       Date:  2015-12-21       Impact factor: 3.452

10.  National outcomes and uptake of laparoscopic gastrectomy for cancer in England.

Authors:  Ravikrishna Mamidanna; Alex M Almoudaris; Alex Bottle; Paul Aylin; Omar Faiz; George B Hanna
Journal:  Surg Endosc       Date:  2013-04-24       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.